Skip to main content

What the FDA labels say about taking them together

Blinatumomab and cyclosporine

Blinatumomab's FDA label of April 14, 2026 names cyclosporine in its drug interactions section; the cyclosporine labels PlainMeds reads (4) do not name blinatumomab. The blinatumomab label: “In these patients, monitor for toxicity (e.g., warfarin) or drug concentrations (e.g., cyclosporine).”

Check it at the source: the blinatumomab FDA label on DailyMed (effective April 14, 2026, Amgen, Inc); the cyclosporine FDA label on DailyMed (effective August 10, 2026, Novartis Pharmaceuticals Corporation).

What does the blinatumomab label say about cyclosporine?

Blinatumomab label, drug interactions

In these patients, monitor for toxicity (e.g., warfarin) or drug concentrations (e.g., cyclosporine).

Source: FDA drug label (BLINCYTO), Amgen, Inc, effective April 14, 2026 (SPL set 38b482a8-960b-4591-9857-5031ecb830aa), via openFDA; the full label on DailyMed

What does the cyclosporine label say about blinatumomab?

Cyclosporine's label (effective August 10, 2026) and its 3 other brand-application labels do not name blinatumomab in these sections. A label lists what its studies and reports found; it is not a complete list.

Source: FDA drug label (Neoral), Novartis Pharmaceuticals Corporation, effective August 10, 2026 (SPL set 94461af3-11f1-4670-95d4-2965b9538ae3), via openFDA; the full label on DailyMed

These are the labels' own sentences. PlainMeds does not grade interactions; a pharmacist or prescriber can say what they mean for one person's medicines.

Both medicines on the record

0Blinatumomab generic labelers
14Cyclosporine generic labelers
BlinatumomabCyclosporine
Labeled forLeukemia, lymphoma and myelomaOrgan transplant rejection, Rheumatoid arthritis
Boxed warningYesYes
Pharmacy cost (NADAC)n/a$1.04 per unit 0.05% eye emulsion
Shortage nowNo current entryNo current entry

Source: FDA NDC Directory, CMS NADAC of October 7, 2026 and the FDA Drug Shortage Database (FDA files October 8, 2026)

What next?